Jason Pitofsky sold $3.8M of REGN stock

Jason Pitofsky, SVP Controller of Regeneron Pharmaceuticals, Inc. (REGN), sold 4,062 shares of REGN stock worth $3.8M, per an SEC Form 4 filed Nov 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 4, 2026, 2 days before it was made public.

REGN has moved -2.8% since the trade date, from $930.67 to $904.35 (Nov 6, 2026 close).